This NVIDIA Partnership Shows How Big AI Can Really Get

NVIDIA chip paired with Lilly branding, symbolizing AI-driven drug discovery and biotech innovation. Key Points NVIDIA’s valuation remains compelling in early 2026, with long-term forecasts suggesting potential gains of 200% to 500% over the next decade. New partnerships—including a $1 billion AI drug discovery initiative with Eli Lilly—highlight NVIDIA’s expanding role beyond GPUs. Analysts cite robotics and accelerated AI adoption as key 2026 growth drivers, with earnings and guidance expected to con ...